Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$45,000.00

Visualizing atomic-level protein: protein contacts of HIV integrase by structural biology

FY 2017-18

Summary
HIV integrase (IN) catalyzes the most essential step in HIV infection: irreversible proviral insertion into host chromosomes. It is also implicated at multiple stages of viral replication. Integrase inhibitor (INI)-based treatment regimens have thus resulted in potent viral restriction and vastly improved patient outcomes. High-level resistance has developed against INIs like raltegravir ; newer INIs like dolutegravir are more potent, but with obscure resistance pathways. The interactome of IN includes DNA, several viral proteins, and numerous cellular factors. The impact of drug resistance on the intermolecular interactions of IN has not been studied. The mechanism of resistance towards newer INIs is also not well understood, nor the clinically observed variable resistance impact across viral subtype. To aid in structural studies of IN, we have raised, cloned and purified monoclonal antibodies against IN and have characterized these for binding to IN constructs of various lengths. We have obtained some putative antibody-IN protein crystals and diffraction data collection is scheduled. We will characterize the interactions of IN to nucleic acids, INIs and key members of its interactome (INI-1, LEDGF and reverse transcriptase), using biochemical and biophysical methods and crystallography. We will show how drug resistance impacts these interactions. This project aims to yield the first structures of HIV integrase in complex with DNA and a clinically relevant INI. It also aims to be the first structural study to show INI-induced drug resistance mechanisms, at the intermolecular level.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
377093
Name
Quashie Peter K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Visualizing atomic-level protein: protein contacts of HIV integrase by structural biology
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Hiv; Host-Virus Interactions; Integrase; Molecular Epidemiology; Protein Crystallography; Structural Biology
Abstract
HIV integrase (IN) catalyzes the most essential step in HIV infection: irreversible proviral insertion into host chromosomes. It is also implicated at multiple stages of viral replication. Integrase inhibitor (INI)-based treatment regimens have thus resulted in potent viral restriction and vastly improved patient outcomes. High-level resistance has developed against INIs like raltegravir ; newer INIs like dolutegravir are more potent, but with obscure resistance pathways. The interactome of IN includes DNA, several viral proteins, and numerous cellular factors. The impact of drug resistance on the intermolecular interactions of IN has not been studied. The mechanism of resistance towards newer INIs is also not well understood, nor the clinically observed variable resistance impact across viral subtype. To aid in structural studies of IN, we have raised, cloned and purified monoclonal antibodies against IN and have characterized these for binding to IN constructs of various lengths. We have obtained some putative antibody-IN protein crystals and diffraction data collection is scheduled. We will characterize the interactions of IN to nucleic acids, INIs and key members of its interactome (INI-1, LEDGF and reverse transcriptase), using biochemical and biophysical methods and crystallography. We will show how drug resistance impacts these interactions. This project aims to yield the first structures of HIV integrase in complex with DNA and a clinically relevant INI. It also aims to be the first structural study to show INI-induced drug resistance mechanisms, at the intermolecular level.
Competitiondate
201711
Approvedterm2
1 yr 0 mth
Pinamesdelim
Quashie, Peter K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $45,000~ $0~